Skip to content

Clinical trials

Macular Degeneration trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Macular Degeneration Country / region: Belgium Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20073
20082
20101
20111
20133
20171
20181
20191
20203
20213
20222
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Terminated3
Unknown status2
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Universitaire Ziekenhuizen KU Leuven5
Novartis Pharmaceuticals4
Brugmann University Hospital2
GlaxoSmithKline2
Janssen Research & Development, LLC2
Novartis2
Pfizer2
Astellas Pharma Global Development, Inc.1
Bayer1
IVERIC bio, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Macular Degeneration26
Choroidal Neovascularization8
Geographic Atrophy7
Vision Disorders3
Eye Diseases2
Retinal Diseases2
Wet Macular Degeneration2
Alzheimer Disease1
Blindness1
Cognitive Dysfunction1

Trials

Showing 51 to 26 of 26. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.